Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Neoleukin Therapeutics Q2 EPS $(0.27) Down From $(0.20) YoY

Neoleukin Therapeutics (NASDAQ:NLTX) reported quarterly losses of $(0.27) per share. This is a 35 percent decrease over losses of $(0.20) per share from the same period last year.

byBenzinga Newsdesk

August 5, 2021

1 minute read

Neoleukin Therapeutics (NASDAQ:NLTX) reported quarterly losses of $(0.27) per share. This is a 35 percent decrease over losses of $(0.20) per share from the same period last year.

How Apogee Registers 10% Sales Growth In Q3: Architectural Framing Systems, Among Other Segments

By Anusuya Lahiri

Today, 11:05 PM

Apogee Enterprises Inc (NASDAQ: APOG) reported third-quarter FY23 sales growth of 10.1% year-over-year to $367.8 million, beating the consensus of $363.4…

APOG

Hope Bancorp Q4 EPS $0.34 Beats $0.31 Estimate

By Benzinga Newsdesk

Today, 11:05 PM

Hope Bancorp (NASDAQ:HOPE) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.31…

HOPE

Chipotle Mexican Grill: Q4 Earnings Insights

By Benzinga Insights

Today, 11:05 PM

Chipotle Mexican Grill (NYSE:CMG) reported its Q4 earnings results on Tuesday, February 8, 2022 at 04:10 PM. Here's what investors need to know about the announcement.

CMG